CIK 0001788028
- Non-accelerated filer
- Smaller reporting company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842984849
- Phone
- +1 650-549-1400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- 4 Grant or award Chief Medical Officer acquired 400 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 900 shares at $26.44 ($23,792)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Former 10% Owner bought 190,000 shares at $12.95 ($2,460,500)
- 4 Open-market buy 10% owner bought 350,000 shares at $12.95 ($4,532,500)
- 4 Open-market buy Director bought 10,000 shares at $0.65 ($6,486)
- 4 Open-market buy Director bought 10,000 shares at $0.64 ($6,383)
- 4 Open-market buy Director bought 30,000 shares at an average $0.61 ($18,240)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 8 · 158 filings